Accreditation
Registration
Abstract Submissions
Overview
Multimedia
Accommodations
Opportunities
Faculty
View Archive

2nd Annual European Congress on Immunotherapies in Cancer™

2nd Annual European Congress on Immunotherapies in Cancer™


22-23 September 2017
Barcelona, Spain

Crowne Plaza Barcelona – Fira Center
Av. de Rius i Taulet, 1,
08004 Barcelona, Spain
Tel: +34 934 26 22 23

Hotel Information Link

Overview

The clinical development of immunotherapies is undoubtedly one of the hottest areas in cancer research today. It is now well appreciated that the tumor microenvironment and the host immune system play important roles in cancer biology. With that understanding, modern-day immunotherapeutic approaches have emerged that do not directly target cancer cells, but harness the adaptive and innate powers of the immune system to combat cancer. These innovative strategies have been practice-changing for the management of a number of malignancies and continue to transform the way clinicians think about treating cancer. While the integration of landmark trial data and new strategies is occurring on an ongoing basis, preclinical and clinical data continue to rapidly accumulate on immunotherapy basic science.

The rapid pace with which new and practice-changing information is emerging creates practice and/or educational gaps for busy clinicians who strive to maintain state-of-the-art care for their patients with cancer. Educational initiatives that allow experts to place noteworthy evidence of immunotherapeutic strategies in its proper clinical context will bridge these educational gaps and optimize clinical practices.

The European Congress on Immunotherapies in Cancer™ is a 2-day comprehensive and interactive program focused exclusively on immunotherapies and their practical application to the management of cancer. This intensive, interactive program will provide a comprehensive review of key data sets that are most relevant for the clinician who manages some of the most difficult-to-treat forms of cancer. The program will focus on scientific advances, recent clinical trial results that shape current and evolving uses of these approaches, proactive methods to monitor and mitigate treatment-related adverse events, current and emerging testing methods, and multidisciplinary team approaches to optimize the use of immunotherapeutic strategies to treat cancer.

Target Audience

This educational activity is intended for medical oncologists and other healthcare professionals (physicians, physicians-in-training, oncology nurses, pharmacists, physician assistants, etc.). Participants will primarily be those whose practice requires mastery and a critical understanding of the fundamental principles, pivotal published studies, and emerging information on immunotherapies and their evolving roles in the treatment of cancer.

Educational Objectives

  • Explain mechanistic approaches toward targeting the immune system to treat cancer
  • Evaluate the clinical applicability of data from clinical trials of immunotherapy strategies
  • Discuss methods to individualize the use of immunotherapy strategies, including the use of biomarkers
  • Describe how to proactively mitigate and manage adverse events associated with the use of treatment strategies used in the care of patients with cancer
  • Identify unmet clinical needs in cancer treatment and highly anticipated clinical trials evaluating novel immunotherapeutic approaches

Program Chair

Antoni Ribas, MD, PhD
Professor of Medicine
Professor of Surgery
Professor of Molecular and Medical Pharmacology
David Geffen School of Medicine
Director, Tumor Immunology Program
Jonsson Comprehensive Cancer Center
University of California, Los Angeles
Los Angeles, California, USA

Co-Chair

Roman Perez-Soler, MD
Chairman, Department of Oncology
Montefiore Medical Center
Professor of Medicine and Molecular Pharmacology
Deputy Cancer Center Director
Albert Einstein College of Medicine
Bronx, New York, USA

European Planning Committee

Joan Carles, MD, PhD
Associate Professor of Medicine. UIC
Director GU, CNS and Sarcoma Program
Department of Medical Oncology
Vall d’Hebron University Hospital
Barcelona, Spain

John B.A.G. Haanen, MD, PhD
Head of the Division of Medical Oncology and Staff Scientist in the Division of Immunology
The Netherlands Cancer Institute
Professor of Translational Immunotherapy of Cancer Leiden University Medical Center
Amsterdam, Netherlands

Jose A Lopez-Martin, MD, PhD
Chairman, GETICA (Grupo Español de Terapias Inmuno-Biologicas en Cancer/Spanish Group for Cancer Immuno-Biotherapy)
Early Clinical and Translational Research Unit
Sarcoma and Melanoma Programme
Medical Oncology Department
'12 de Octubre' University Hospital
Madrid, Spain

Caroline Robert, MD PhD
Head of the Dermatology Unit
Department of Medicine
Gustave Roussy and Paris-Sud University
Villejuif Grand -Paris, France




Register

You must be logged in to PER to register for this meeting

Or Register for PER now

*Required Fields

Login Information


Registration Information


In case of onsite emergency:

Professional Information


Specialties*

Assumption of Risk and Waiver of Liability Relating to Coronavirus/COVID-19

I understand that the hazards of the novel coronavirus ("COVID-19") and have reviewed the Centers for Disease Control and Prevention ("CDC") current guidelines in regards to COVID-19. I acknowledge that while Physicians' Education Resource, LLC ("PER") ("Company") has put in place preventative measures to reduce the spread of COVID-19, Company cannot guarantee that I or anyone else will not become infected with COVID-19. I attest that if within the fourteen (14) days prior to the event, I am experiencing any symptoms of COVID-19, or I have been in close contact with anyone that has been diagnosed with COVID-19, then I will not attend the Activities. I shall follow any safety, social distancing, masking, and hygiene protocols that have been implemented at the Activities.

I hereby willingly and voluntarily choose to attend this PER event and related activities ("Activity"). I acknowledge and fully assume the risk and hazards of exposure to COVID-19 and that such exposure or infection may result in personal injury, illness, permanent disability, and death to myself, my spouse, children, unborn child, or relatives. I acknowledge that Company may share my personal information for the purpose of contact tracing if the need arises, and I hereby consent to the release of my personal information for such purpose. I hereby release covenant not to sue, forever discharge, and hold harmless Company and its affiliates from all liability claims and demands of whatever kind of nature, either in law or in equity, which arise or may hereafter arise from participating in the Activities. I assume all risks of losses, damages, or injuries that may be sustained while participating in the Activity. I understand and agree that this release includes any Claims based on the actions, omissions, or negligence of the venue, employees, vendors, agents, and representatives, whether a COVID-19 infection occurs before, during, or after participation in the Activity.

* By checking this box, you have read and understand the above and agree to its terms.

Submit
Calendar of Events
SUNMONTUESWEDTHURSFRISAT
    123
45678910
11121314151617
18192021222324
252627282930
Filter By